Mitsubishi Chemical Denies Sale Reports of Mitsubishi Tanabe Pharma
Mitsubishi Chemical (TYO:4188) has denied recent reports by Nikkei suggesting it is negotiating the sale of Mitsubishi Tanabe Pharma Corporation, according to a Monday filing on the Tokyo Stock Exchange.
The company clarified that it has not announced any such sale and emphasized that no such transaction is currently underway.
Mitsubishi Chemical is actively reviewing its business portfolio, including its pharmaceutical segment, and is considering various strategic options, including divestitures.
Price (JPY): $911.60, Change: $+11, Percent Change: +1.17%